Testing effectiveness (Phase 2)WithdrawnNCT05728736What this trial is testingAcute Effect of Lemborexant on CSF Amyloid-Beta and TauWho this might be right forAlzheimer Disease Brendan Lucey
Not applicableStudy completedNCT02063217What this trial is testingModulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep InductionWho this might be right forAmyloid-beta Washington University School of Medicine 36
Not applicableEnded earlyNCT05820932What this trial is testingPredicting Cognitive Decline From Androgen Deprivation TherapyWho this might be right forProstate Cancer University of California, San Francisco 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768What this trial is testingAV-1959R Vaccine in Individuals With Preclinical Alzheimer's DiseaseWho this might be right forPreclinical Alzheimer's DiseaseAlzheimer Disease Institute for Molecular Medicine 160
Not applicableStudy completedNCT02770482What this trial is testingAmyloid Beta-peptide 1-40 and Alzheimer's DiseaseWho this might be right forAlzheimer Disease CHU de Reims 204
Testing effectiveness (Phase 2)Study completedNCT04497168What this trial is testingCitalopram as a Posterior Cortical Protective Therapy in Parkinson DiseaseWho this might be right forParkinson Disease University of Michigan 58
Not applicableStudy completedNCT05527288What this trial is testingA Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese PopulationWho this might be right forAlzheimer DiseaseDementiaBrain Diseases+6 more Sinotau Pharmaceutical Group 50
Large-scale testing (Phase 3)Study completedNCT01561053What this trial is testingEvaluate Albumin and Immunoglobulin in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Instituto Grifols, S.A. 347
Testing effectiveness (Phase 2)Ended earlyNCT00299988What this trial is testingPhase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Weill Medical College of Cornell University 24
Early research (Phase 1)Study completedNCT01424436What this trial is testingModulation of Abeta Levels by GSK933776 in Alzheimer's Disease PatientWho this might be right forAlzheimer's Disease GlaxoSmithKline 19
Not applicableStudy completedNCT01857830What this trial is testingThe Relaxation vs. Retreat StudyWho this might be right forStressAgeingWellbeing University of California, San Francisco 96
Not applicableNot Yet RecruitingNCT07521722What this trial is testingDIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse CommunityWho this might be right forAlzheimer DiseaseCognitive Dysfunction, Cognitive DisorderDementia+1 more Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 250
Not applicableStudy completedNCT03899844What this trial is testingStudy to Evaluate Amyloid in Blood and Imaging Related to DementiaWho this might be right forAlzheimer DiseaseAlzheimer Dementia Washington University School of Medicine 1,122
Early research (Phase 1)Not Yet RecruitingNCT07142278What this trial is testingDUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and TauWho this might be right forAlzheimer DiseaseAlzheimer Disease (AD)Preclinical Alzheimer's Disease Nuravax, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06659549What this trial is testingEfficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDWho this might be right forGeographic Atrophy of the Macula Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT02646982What this trial is testingCandesartan's Effects on Alzheimer's Disease And Related BiomarkersWho this might be right forMild Cognitive Impairment Emory University 77
Very early researchStudy completedNCT01217021What this trial is testingSafety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558Who this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 10
Not applicableStudy completedNCT06083233What this trial is testingRole of Brain Specific Biomarkers in HydrocephalusWho this might be right forHydrocephalus, Normal PressureBiochemical Lesions Head RegionBrain Damage University Hospital Hradec Kralove 32
Early research (Phase 1)Study completedNCT00765115What this trial is testingHealthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.Who this might be right forAlzheimer Disease Eli Lilly and Company 27
Early research (Phase 1)Study completedNCT00448799What this trial is testingEvaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy ControlsWho this might be right forAlzheimers Disease Molecular NeuroImaging 30